The physiological effect of hyperoxia has been poorly characterised, with studies reporting 2 conflicting results on the role of hyperoxia as a vasoconstrictor. It is not clear whether 3 hyperoxia is the primary contributor to vasoconstriction or whether induced changes in CO 2 4 that commonly accompany hyperoxia are a factor. As calibrated BOLD fMRI based on 5 hyperoxia becomes more widely used, it is essential to understand the effects of oxygen on 6 resting cerebral physiology. This study used a RespirAct TM system to deliver a repeatable 7 isocapnic hyperoxia stimulus to investigate the independent effect of O 2 on cerebral 8 physiology, removing any potential confounds related to altered CO 2 . T 1 -independent Phase 9
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Running title: Hyperoxia and the resting-state brain. hence decreasing the concentration of deoxyhaemoglobin in capillaries and veins (Rostrup et 10 al., 1995) . This leads to an increase in the transverse relaxation time (T 2 * ) of blood in vessels 11 and the surrounding tissue, and thus a global increase in the BOLD-MRI signal (Losert et al., 12 2002, Ogawa and Lee, 1990) . focal invasive electrode recordings (rat whisker studies (Lindauer et al., 2003) ). 28
Magnetoencephalography (MEG) provides a non-invasive method of spatially resolving the 29 electrophysiological effects of hyperoxia across cortical grey matter. 30
31
The aim of this study was to assess changes in blood flow and localised neuronal activity in 32 response to isocapnic hyperoxia. We used a RespirAct TM (Thornhill Research Inc., Toronto, 33 Canada) system to provide independent control of end-tidal levels of O 2 (P ET O 2 ) and CO 2 34 1 Experiment 1: Phase Contrast MRI flow measurement under hyperoxia and hypercapnia. The 2 experiment involved 1 minute of normoxic baseline followed by 5 minutes of isocapnic 3 hyperoxia (P ET O 2 targeted at 500mmHg, equivalent to F i O 2 = 0.6, at subject's resting 4 P ET CO 2 , included as a positive control), and then 5 minutes of normoxic baseline. This was 5 then followed by 2 cycles of 2 minutes of hypercapnia (subject's resting P ET O 2 , P ET CO 2 6 targeted at baseline + 8mmHg), separated by 2 minutes of baseline, followed by 1 minute of 7 baseline ( Figure 1A ). The total duration of the respiratory challenge was 20 minutes, 8 including transitions between the different blood gas levels. All hyperoxia transitions 9 consisted of a graded increase/decrease in target PETO 2 (between subject specific baseline 10 and 500mmHg across 1 minute) in order to minimise a sudden influx of gas, as is common 11 with a square-wave transition. This minimises discrepancies between targeted and actual 12 PETO 2 , allowing a steady-state to be reached near instantaneously. give an average carotid artery flux waveform at normoxia, hyperoxia and hypercapnia. These 3 data were then averaged across all subjects to give a mean response across cardiac cycle, and 4 across all phases of the cardiac cycle to provide a single value from which to estimate mean 5 blood flow (MBF) at normoxia, hyperoxia and hypercapnia. The change in MBF induced by 6 hyperoxia and hypercapnia was then assessed using a non-parametric Wilcoxon signed rank 7 test (SPSS 16, Chicago, IL, USA), and the % change in MBF per mmHg CO 2 caluclated for 8 each subject and averaged. The variance between the repeat measures of MBF calculated 9 normoxia was assessed to estimate the minimum detectable change (MDC) in MBF at a 10 significance of P = 0.05. 11
12
Experiment 2: aCBV response to hyperoxia: This experiment involved 1 minute of baseline 13 followed by 2 minutes of isocapnic hyperoxia (P ET O 2 targeted at 500 mmHg, subject's resting 14 P ET CO 2 ) and 1 minute of baseline ( Figure 1B ). P ET CO 2 was maintained at subject specific 15 resting levels throughout. The duration of the respiratory challenge was 6 minutes, including 16 transitions. 17 was acquired and a series of inversion recovery EPI images (10 inversion times, 100 -2600 25 ms) which were fitted for T 1 . A grey matter (GM) mask was then formed by thresholding the 26 T 1 map at 1.7 ≤ T 1 ≤ 2.3 s. The mean GM aCBV and arterial transit time (Δ arterial ) were then 27 calculated. First aCBV weighted difference images were formed by subtraction of the label 28 from control images ( Figure 3A) . The average aCBV difference signal within the GM mask 29 for each LL-readout was then estimated, for both the normoxia and hyperoxia periods. These 30 signal curves were then normalised by the base magnetisation blood signal from the middle 31 cerebral artery, and the resulting normalised aCBV signal curves at normoxia and hyperoxia 32 fitted for GM aCBV and Δ arterial as described in (Brookes et al., 2007) . This fitting required an 33 estimate of T 1blood on normoxia and hyperoxia. The measurement of T 1blood at normoxia and 34 hyperoxia in vivo in humans at 7 T is difficult due to its fast flow rate and the limited 1 coverage of the head transmit coil, therefore we assumed a T 1 of arterial blood (F i O 2 = 0.2) at 2 7 T of 2200 ms (T1 blood normoxia) ( an area associated with cognitive processing in working memory (Brookes et al., 2010) . 23 Oscillatory amplitude envelopes for each frequency band were averaged across periods of 24 hyperoxia and normoxia, and the resulting spectra averaged across subjects. Significant 25 differences (where p < 0.05) between hyperoxia and normoxia were tested using a non-26 parametric Wilcoxon signed rank test with Bonferroni correction for multiple comparisons. 27
RESULTS 1

Experiment 1: PC-MRI flow measurement under hyperoxia and hypercapnia:
One of the six 2 subjects was excluded due to the tortuous configuration of their ICAs, preventing the imaging 3 slice being placed perpendicular to both left and right ICA simultaneously. The mean 4 hyperoxic step (± standard error in mean (SEM)) was 460 ± 13 mmHg, with a baseline of 111 5 ± 7 mmHg averaged across subjects, while P ET CO 2 varied by less than 1 mmHg. The mean 6 hypercapnic step was 4.2 ± 0.5 mmHg, while P ET O 2 varied by less than 1 mmHg. 7 Hyperoxia did not cause a significant change in MBF (paired t-test, power = 0. assessed from repeated measures of normoxic MBF, was found to be 3.6 %, again less than 12 the MBF change reported previously. As expected, an increase in MBF occurred during 13 hypercapnia compared to normoxia of 6.8 ± 1.5 % per mmHg CO 2 (power = 0.08, p = 0.03). 14 Figure 2D shows the variation in MBF across the cardiac cycle during normoxia, hyperoxia 15 and hypercapnia averaged across subjects. 16
17
Experiment 2: aCBV response to hyperoxia: The mean hyperoxic step (± SEM) was 486 ± 12 18 mmHg, with a baseline of 119 ± 1 mmHg averaged across subjects, while P ET CO 2 varied by 19 less than 2 mmHg. Figure 3A shows the aCBV-weighted LL-FAIR ASL data in a 20 representative subject, from which the mean GM aCBV was measured to be 1. hyperoxia on total CBV is also under debate (Kolbitsch et al. 2002) . aCBV was measured 4 using LL-FAIR ASL which is a multiphase readout ASL sequence, allowing aCBV and 5 arterial transit time to be fitted simultaneously. This is important since a change blood flow is 6 often also accompanied by a change in transit time, and these changes may act in opposition. 7
Therefore if a constant transit time is assumed at a single inversion time, changes in aCBV 8 may be masked. The reduction in T 1blood that occurs during hyperoxia can cause an apparent 9 change in the ASL aCBV weighted signal in the absence of any actual change in aCBV. In 10 this work we took account of this effect by fitting the aCBV data assuming a reduction in 11 T 1blood during hyperoxia (from 2200 ms at normoxia to 1986 ms at hyperoxia), where these 12 values were estimated by extrapolating from the literature values at other field strengths and 13 levels of oxygenation. 14 
15
To investigate the effect of neglecting such a reduction in T 1blood on the fitted value of aCBV, 16 the aCBV weighted signal was simulated using the LL-FAIR ASL sequence timings used in 17 this experiment (Brookes et al., 2007) , with additional simulation parameters given in Table  18 2. Simulating aCBV weighted LL-FAIR ASL data (100 iterations, SNR = 100:1) with T 1blood 19 of 1892 ms (for hyperoxia) and fitting the data assuming T1 blood of 2200 ms (normoxia value) 20 led to aCBV being underestimated by 10 ± 0.3 % (error in fitted mean ± SEM across 21 iterations), while Δ arterial remained largely unaffected (underestimated by 0.6 ± 0.5 %). Maleki calibration. However, we find that isocapnic hyperoxia induces neural oscillatory changes 34 that are smaller in magnitude and spatial extent across subjects compared to iso-oxic 1 hypercapnia which implies that isocapnic hyperoxia is a more appropriate stimulus than 2 hypercapnia for calibrating the BOLD response (Chiarelli et al., 2007b) . This said, the small 3 focal effect of hyperoxia on neural signals remains significant, suggesting that further 4 investigation is required in order to determine if the observed change may lead to an 5 under/overestimation of CMRO 2 in these areas. The significant but differential effects of 6 hyperoxia and hypercapnia on neural oscillatory processes may be of even greater importance 7 to the more recent combined calibrated BOLD models (Bulte et al., 2012, Gauthier and Hoge, 8 2012) . Further investigation would allow quantification of separate hyperoxia and 9 hypercapnia CMRO 2 error terms in order to gain equivalent calibration constants which can 10 then be combined 11
12
CONCLUSION 13
This study addresses the main physiological assumptions made in hyperoxia-based calibrated 14 BOLD, and has found no significant effect of isocapnic hyperoxia on GM aCBV or global 15 MBF in the internal carotid arteries. While hyperoxia was shown to produce significant 16 changes in neuronal oscillations consistent with increased vigilance as measured using source 17 localised MEG, the changes were both more focal and of significantly smaller amplitude than Targeted respiratory paradigms for A) Experiment 1; isocapnic hyperoxia (P ET O 2 = 2 500 mmHg) followed by 2 cycles of iso-oxic hypercapnia (subject specific baseline P ET CO 2 + 3 8 mmHg) B) Experiment 2; isocapnic hyperoxia (P ET O 2 = 500 mmHg), P ET CO 2 targeted at 4 subject-specific baseline throughout and C) Experiment 3; 2 cycles of isocapnic hyperoxia 5 (P ET O 2 = 500 mmHg), P ET CO 2 targeted at subject-specific baseline throughout. Requested 6 end tidal pressure of O 2 is traced in black and CO 2 in grey. 
